4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-014988
Senior Vice President and CFO sold 7,500 shares at $8.81 ($66,075)
- Senior Vice President and CFO acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
STAAB THOMAS R II · Senior Vice President and CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-04-04 | Exercise or conversion : show line 1 in the form | +7,500 | $5.51 | $41,325 | 140,176 | D |
| 2019-04-04 | Sale : show line 2 in the form | −7,500 | $8.81 | $66,075 | 132,676 | D |
| Open-market sales · 7,500 sh · avg $8.81 · $66,075 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-04-04 | Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) | −7,500 | 167,500 | D |
Loading xslF345X03/form4.xml…